Orphenadrine Extended-Release Tablets and Pertuzumab Intravenous
Determining the interaction of Orphenadrine Extended-Release Tablets and Pertuzumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Orphenadrine
Generic Name: pertuzumab
Brand name: Perjeta
Synonyms: Pertuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Orphenadrine Extended-Release Tablets-Pertzye
- Orphenadrine Extended-Release Tablets-Pexeva
- Orphenadrine Extended-Release Tablets-Pexidartinib
- Orphenadrine Extended-Release Tablets-Pexidartinib Hydrochloride
- Orphenadrine Extended-Release Tablets-Pfizerpen
- Orphenadrine Extended-Release Tablets-Pharaon Tea
- Pertuzumab Intravenous-Orphenadrine Injection
- Pertuzumab Intravenous-Orphenadrine w/A.C.
- Pertuzumab Intravenous-Orphenadrine, aspirin, and caffeine
- Pertuzumab Intravenous-Orphenate
- Pertuzumab Intravenous-Orphengesic
- Pertuzumab Intravenous-Orphengesic Forte